Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend
Max Healthcare's Board approved FY26 audited results and recommended a final dividend of ₹2 per share. The company also approved the construction of a new hospital in Lucknow and the shifting of its registered office to Haryana. Mr. Anil Kumar Bhatnagar was re-appointed as a director.
The approval of financial results and dividend recommendation are routine but positive. The strategic decisions like hospital construction and office relocation have medium-term implications for the company's operations and growth.
The approval of financial results, recommendation of dividend, and strategic expansion plans (new hospital construction, office relocation) indicate positive developments for the company.
Max Healthcare Institute Limited announced the outcome of its Board Meeting held on May 21, 2026. The Board approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The company's statutory auditors, S.R. Batliboi & Co. LLP, have issued an auditor's report with an unmodified opinion.
In addition to the financial results, the Board recommended a final dividend of ₹2 per equity share (20% of face value) for the financial year 2025-26, subject to shareholder approval. This dividend will be paid/dispatched within 30 days from the conclusion of the forthcoming Annual General Meeting (AGM).
The Board also approved the re-appointment of M/s. Chandra Wadhwa & Co. as Cost Accountants for the financial year 2026-27. Furthermore, the request for re-classification of Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category was considered and approved, pending stock exchange approvals.
Significant strategic decisions included the approval for the construction of Phase-I of Max Super Specialty Hospital in Lucknow, which will accommodate approximately 712 beds. The company also received approval for shifting its registered office from Maharashtra to Haryana, subject to member and regulatory approvals.
Mr. Anil Kumar Bhatnagar was re-appointed as Non-Executive and Non-Independent Director for a further period of three years, effective October 1, 2026, subject to member approval at the AGM.
The Board meeting commenced at 12:07 PM IST and concluded at 3:44 PM IST.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.